Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study
CONCLUSION: HIPEC can improve survival in GC patients with synchronous peritoneal metastases who have primary tumor resection, but not in those without primary tumor resection.PMID:37947869 | DOI:10.1007/s00432-023-05481-9
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Jianping Guo Zijian Deng Longyang Jin Shi Yin Zhizhong Xiong Caiqin Wang Huaxian Chen Dandong Luo Dayin Huang Junsheng Peng Shi Chen Lei Lian Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Peritoneal Cancer | Study